Company intelligence / Profile preview

3Brain

Wädenswil, Zurich, Switzerland3brain.com ↗

Ownership: Private
Employees: ~59
Development stage: Commercial

Overview

3Brain has developed and commercialized the world’s first CMOS-based high-resolution microelectrode array biosensor, enabling non-invasive in vitro investigations of electrogenic cells such as neurons and cardiac cells. Their technology supports advanced research into brain diseases and drug discovery by providing superior spatial and temporal resolution for cell-based assays[1][2][4].

Modalities: DeviceBiosensorIn vitro assay platform (CMOS-based high-density microelectrode array)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on 3Brain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3Brain.

Explore the full profile